RxDoctor Payments Data

Christina Ricciardi

Nurse Practitioner · Bayside, NYNPI 1396384921

Payments from drug & device makers

$7,972in general payments, 2019–2025

Across 172 payments — averaging $46.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$3K
  • Bayer$1K
  • Sumitomo Pharma America, Inc.$699
  • Astellas Pharma US Inc$619
  • Pfizer$420
  • Myovant Sciences Inc.$247
  • plus $2K from 19 others

What the payments were for

  • Consulting fees$2,80435%
  • Speaking & faculty fees$3605%
  • Travel & lodging$4666%
  • Food & beverage$4,07351%
  • Education$2693%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,972 in reported general payments places this provider in the 95th percentile of 4,112 nurse practitioner providers in New York.

See all nurse practitioner providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
XtandiEnzalutamide11$140,604
OrgovyxRelugolix28$74,946
GemtesaVibegron52$46,290
XgevaDenosumab12$37,614
MyrbetriqMirabegron57$33,653
Tamsulosin Hcl447$6,680
Trospium Chloride98$4,342
Testosterone16$2,628
Trospium Chloride ErTrospium Chloride17$2,258
Tadalafil33$2,215
Methenamine Hippurate56$2,020
Potassium Citrate ErPotassium Citrate14$1,989
Finasteride140$1,469
Alfuzosin Hcl ErAlfuzosin Hcl107$1,278
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst53$1,277

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncXtandi, Myrbetriq$619$174,25768 claims
Sumitomo Pharma America, Inc.Orgovyx, Gemtesa$699$121,23580 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,112 nurse practitioner providers in New York.

Other nurse practitioner in Bayside

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →